| Sign In to gain access to subscriptions and/or personal tools. |
Primary aromatic amines: their N-oxidative bioactivationWalther-Straub-Institut für Pharmakologie und Toxikologie der Universität München, Nussbaumstrasse 26, D-80336 München
Hermes Arzneimittel GmbH, Georg-Kalb-Strasse 5-8, D-82049 Grosshesselohe, Germany
Walther-Straub-Institut für Pharmakologie und Toxikologie der Universität München, Nussbaumstrasse 26, D-80336 München
Walther-Straub-Institut für Pharmakologie und Toxikologie der Universität München, Nussbaumstrasse 26, D-80336 München There exists a diversity of pathways in mammalian cells serving to activate primary aromatic amines. 1 N-Oxidative mixed-function turnover usually involves participation of the cytochrome P450 superfamily, while catalysis by the flavin-containing monooxy genases is restricted to a few amines capable of forming imine tautomers. Surprisingly, haemoglobin metabo lizes cytotoxic and carcinogenic arylamines via a monooxygenase-like mechanism, but peroxygenase activity is also operative. 2 In extrahepatic tissues that exhibit only a low level of monooxygenases, peroxidative transformations, as are brought about by prostaglandin H synthase, myeloperoxidase or lactoperoxidase, predominate in amine activation. Non-mammalian peroxidases fre quently used as model systems include horseradish peroxidase and chloroperoxidase. 3 Non-enzymatic, light-induced conversion of aromatic amines to free radical or N-oxy products proceeds either via direct photolysis of the nitrogenous com pounds or through attack by lipid-derived reactive intermediates generated during irradiation. 4 The interplay of the various tissue-specific processes of arylamine activation serves to explain differences in susceptibility toward the biological actions of primary aromatic amines.
Key Words: primary arylamines N-oxygenation enzymology toxicity
Human & Experimental Toxicology, Vol. 16, No. 8,
441-448 (1997) This article has been cited by other articles:
|
|||||||||||||||||||||||||||

